Literature DB >> 16263848

The construct of minor and major depression in Alzheimer's disease.

Sergio E Starkstein1, Ricardo Jorge, Romina Mizrahi, Robert G Robinson.   

Abstract

OBJECTIVE: This study examined the frequency of major and minor depression in Alzheimer's disease and determined whether these types of depression have a different functional and psychopathological impact and whether there is a change in the prevalence of major and minor depression throughout the stages of Alzheimer's disease.
METHOD: A consecutive series of 670 patients with probable Alzheimer's disease were assessed with the Structured Clinical Interview for DSM-IV; specific instruments to rate the presence and severity of depression, anxiety, apathy, irritability, delusions, pathological affective crying, performance of activities of daily living, and social functioning; and a standardized neuropsychological evaluation. Diagnoses of major and minor depression were generated from DSM-IV criteria.
RESULTS: Twenty-six percent of the patients had major depression, 26% had minor depression, and 48% were not depressed. Major depression was significantly associated with sad mood in all three stages of the illness, although this association dropped significantly for minor depression in severe Alzheimer's disease. Both major and minor depression were significantly associated with more severe psychopathology, functional impairments, and social dysfunction. Depressive symptoms that most strongly discriminated between Alzheimer's disease patients with and without sad mood were guilty ideation, suicidal ideation, loss of energy, insomnia, weight loss, psychomotor retardation/agitation, poor concentration, and loss of interest.
CONCLUSIONS: Our study demonstrates that DSM-IV criteria for major and minor depression identify clinically relevant syndromes of depression in Alzheimer's disease, mild levels of depression can produce significant functional impairment, and the severity of psychopathological and neurological impairments increases with increasing severity of depression.

Entities:  

Mesh:

Year:  2005        PMID: 16263848     DOI: 10.1176/appi.ajp.162.11.2086

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  71 in total

1.  Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia.

Authors:  Mirjam I Geerlings; Adam M Brickman; Nicole Schupf; Davangere P Devanand; José A Luchsinger; Richard Mayeux; Scott A Small
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults.

Authors:  Thomas W Meeks; Ipsit V Vahia; Helen Lavretsky; Ganesh Kulkarni; Dilip V Jeste
Journal:  J Affect Disord       Date:  2011-03       Impact factor: 4.839

Review 4.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

5.  Depressive symptoms in Chinese-American subjects with cognitive impairment.

Authors:  Steven Z Chao; Brandy R Matthews; Jennifer S Yokoyama; Ngan Betty Lai; Hilary Ong; Marian Tse; Runfen Frances Yuan; Amy Lin; Joel Kramer; Kristine Yaffe; John Kornak; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

6.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

7.  Treatments for Depression in Older Persons with Dementia.

Authors:  Zvi D Gellis; Kimberly P McClive-Reed; Ellen Brown
Journal:  Ann Longterm Care       Date:  2009-02-02

8.  Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia.

Authors:  Thomas S Wingo; Jingjing Yang; Wen Fan; Se Min Canon; Ekaterina Sergeevna Gerasimov; Adriana Lori; Benjamin Logsdon; Bing Yao; Nicholas T Seyfried; James J Lah; Allan I Levey; Patricia A Boyle; Julia A Schneider; Philip L De Jager; David A Bennett; Aliza P Wingo
Journal:  NPJ Genom Med       Date:  2020-02-06       Impact factor: 8.617

Review 9.  Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.

Authors:  Jimmy Choi; Elizabeth W Twamley
Journal:  Neuropsychol Rev       Date:  2013-02-12       Impact factor: 7.444

10.  Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia.

Authors:  Mirjam I Geerlings; Sigurdur Sigurdsson; Gudny Eiriksdottir; Melissa E Garcia; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Neurology       Date:  2015-08-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.